Hoth Free Cash Flow vs Current Ratio Analysis
HOTH Stock | USD 1.38 0.11 7.38% |
Hoth Therapeutics financial indicator trend analysis is much more than just examining Hoth Therapeutics latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Hoth Therapeutics is a good investment. Please check the relationship between Hoth Therapeutics Free Cash Flow and its Current Ratio accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Hoth Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. For more detail on how to invest in Hoth Stock please use our How to Invest in Hoth Therapeutics guide.
Free Cash Flow vs Current Ratio
Free Cash Flow vs Current Ratio Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Hoth Therapeutics Free Cash Flow account and Current Ratio. At this time, the significance of the direction appears to have strong relationship.
The correlation between Hoth Therapeutics' Free Cash Flow and Current Ratio is 0.65. Overlapping area represents the amount of variation of Free Cash Flow that can explain the historical movement of Current Ratio in the same time period over historical financial statements of Hoth Therapeutics, assuming nothing else is changed. The correlation between historical values of Hoth Therapeutics' Free Cash Flow and Current Ratio is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Free Cash Flow of Hoth Therapeutics are associated (or correlated) with its Current Ratio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Current Ratio has no effect on the direction of Free Cash Flow i.e., Hoth Therapeutics' Free Cash Flow and Current Ratio go up and down completely randomly.
Correlation Coefficient | 0.65 |
Relationship Direction | Positive |
Relationship Strength | Significant |
Free Cash Flow
The amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets.Current Ratio
A liquidity ratio that measures a company's ability to pay short-term obligations or those due within one year. It compares a firm's current assets to its current liabilities.Most indicators from Hoth Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Hoth Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Hoth Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. For more detail on how to invest in Hoth Stock please use our How to Invest in Hoth Therapeutics guide.The current Selling General Administrative is estimated to decrease to about 4.6 M. The current Issuance Of Capital Stock is estimated to decrease to about 9.4 M
Hoth Therapeutics fundamental ratios Correlations
Click cells to compare fundamentals
Hoth Therapeutics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Hoth Therapeutics fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 2.8M | 5.2M | 11.0M | 6.8M | 7.8M | 5.1M | |
Other Current Liab | 36.2K | 182.7K | 506.8K | 692.7K | 796.7K | 836.5K | |
Total Current Liabilities | 440.1K | 312.1K | 867.8K | 1.4M | 1.6M | 1.7M | |
Total Stockholder Equity | 2.4M | 4.6M | 9.9M | 5.1M | 5.9M | 4.3M | |
Net Tangible Assets | 154.7K | 2.4M | 4.6M | 9.9M | 11.4M | 11.9M | |
Net Debt | (1.7M) | (2.6M) | (8.5M) | (6.4M) | (5.8M) | (5.5M) | |
Retained Earnings | (12.2M) | (19.4M) | (33.7M) | (45.1M) | (40.6M) | (38.6M) | |
Accounts Payable | 403.9K | 129.5K | 361.0K | 695.0K | 799.2K | 839.2K | |
Cash | 1.7M | 2.6M | 8.5M | 6.4M | 7.4M | 3.8M | |
Non Current Assets Total | 201.0K | 460K | 410K | 33K | 38.0K | 36.1K | |
Non Currrent Assets Other | 200K | 50K | 410K | 33K | 38.0K | 36.1K | |
Cash And Short Term Investments | 2.5M | 4.7M | 10.4M | 6.6M | 7.6M | 4.7M | |
Common Stock Shares Outstanding | 366.6K | 494.5K | 893.2K | 1.2M | 1.1M | 1.7M | |
Liabilities And Stockholders Equity | 2.8M | 5.2M | 11.0M | 6.8M | 7.8M | 5.1M | |
Non Current Liabilities Total | 403.9K | 285K | 235K | 250K | 287.5K | 250.1K | |
Other Stockholder Equity | 14.6M | 24.1M | 43.6M | 50.2M | 57.7M | 60.6M | |
Total Liab | 440.1K | 597.1K | 1.1M | 1.6M | 1.9M | 2.0M | |
Net Invested Capital | 2.4M | 4.6M | 9.9M | 5.1M | 5.9M | 4.3M | |
Total Current Assets | 2.6M | 4.8M | 10.6M | 6.7M | 7.7M | 4.8M | |
Net Working Capital | 2.2M | 4.5M | 9.7M | 5.3M | 6.1M | 4.2M | |
Common Stock | 1.0K | 1.3K | 2.4K | 130.0 | 149.5 | 142.03 | |
Other Current Assets | 140.6K | 89.8K | 94.0M | 88.5K | 101.7K | 96.6K | |
Capital Stock | 1.0K | 1.3K | 2.4K | 130.0 | 149.5 | 142.03 |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Hoth Therapeutics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Hoth Therapeutics' short interest history, or implied volatility extrapolated from Hoth Therapeutics options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Hoth Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. For more detail on how to invest in Hoth Stock please use our How to Invest in Hoth Therapeutics guide.You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Complementary Tools for Hoth Stock analysis
When running Hoth Therapeutics' price analysis, check to measure Hoth Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hoth Therapeutics is operating at the current time. Most of Hoth Therapeutics' value examination focuses on studying past and present price action to predict the probability of Hoth Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hoth Therapeutics' price. Additionally, you may evaluate how the addition of Hoth Therapeutics to your portfolios can decrease your overall portfolio volatility.
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Transaction History View history of all your transactions and understand their impact on performance | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |
Is Hoth Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Hoth Therapeutics. If investors know Hoth will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Hoth Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.71) | Return On Assets (0.54) | Return On Equity (1.01) |
The market value of Hoth Therapeutics is measured differently than its book value, which is the value of Hoth that is recorded on the company's balance sheet. Investors also form their own opinion of Hoth Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Hoth Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Hoth Therapeutics' market value can be influenced by many factors that don't directly affect Hoth Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Hoth Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Hoth Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Hoth Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.